Junlong Wu

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, The Affiliated Hospital to Changchun University of Chinese Medicine · ORCID：0000-0002-4125-7975

发表论文 115 篇 · 总被引 1816 次 · h-index 25

代表论文

• The global, regional, and national burden of oral cancer, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2025 · Journal of Cancer Research and Clinical Oncology · 被引 37)
• Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial (2024 · Molecular Cancer · 被引 27)
• Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study (2024 · Therapeutic Advances in Medical Oncology · 被引 14)
• Network meta-analysis of combination strategies in metastatic hormone-sensitive prostate cancer (2024 · Asian Journal of Andrology · 被引 9)
• Neoadjuvant fuzuloparib combined with abiraterone for localized high-risk prostate cancer (FAST-PC): A single-arm phase 2 study (2025 · Cell Reports Medicine · 被引 8)
• Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer (2024 · Med · 被引 8)